BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 2651903)

  • 1. The bcl-2 candidate proto-oncogene product is a 24-kilodalton integral-membrane protein highly expressed in lymphoid cell lines and lymphomas carrying the t(14;18) translocation.
    Chen-Levy Z; Nourse J; Cleary ML
    Mol Cell Biol; 1989 Feb; 9(2):701-10. PubMed ID: 2651903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the bcl-2 oncogene protein is not specific for the 14;18 chromosomal translocation.
    Pezzella F; Tse AG; Cordell JL; Pulford KA; Gatter KC; Mason DY
    Am J Pathol; 1990 Aug; 137(2):225-32. PubMed ID: 2201196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Bcl-2 protein and Bcl-2 mRNA in normal and neoplastic lymphoid tissues.
    Akagi T; Kondo E; Yoshino T
    Leuk Lymphoma; 1994 Mar; 13(1-2):81-7. PubMed ID: 8025526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topographical dissociation of BCL-2 messenger RNA and protein expression in human lymphoid tissues.
    Chleq-Deschamps CM; LeBrun DP; Huie P; Besnier DP; Warnke RA; Sibley RK; Cleary ML
    Blood; 1993 Jan; 81(2):293-8. PubMed ID: 8422456
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2.
    Strasser A; Harris AW; Bath ML; Cory S
    Nature; 1990 Nov; 348(6299):331-3. PubMed ID: 2250704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression in non-Hodgkin's lymphoma of the bcl-2 protein associated with the t(14;18) chromosomal translocation.
    Ngan BY; Chen-Levy Z; Weiss LM; Warnke RA; Cleary ML
    N Engl J Med; 1988 Jun; 318(25):1638-44. PubMed ID: 3287162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas.
    Cerroni L; Volkenandt M; Rieger E; Soyer HP; Kerl H
    J Invest Dermatol; 1994 Feb; 102(2):231-5. PubMed ID: 8106752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. t(2;18) and t(18;22) variant chromosomal translocations and bcl-2 gene rearrangements in human malignant lymphomas.
    Larsen CJ; Mecucci C; Leroux D
    Nouv Rev Fr Hematol (1978); 1990; 32(6):401-3. PubMed ID: 2129304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. bcl-2 gene expression in hematopoietic cell differentiation.
    Mariano MT; Moretti L; Donelli A; Grantini M; Montagnani G; Di Prisco AU; Torelli G; Torelli U; Narni F
    Blood; 1992 Aug; 80(3):768-75. PubMed ID: 1638028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The bcl-2 gene and 14;18 translocation in lymphoproliferative disorders.
    Pezzella F; Mason DY
    Nouv Rev Fr Hematol (1978); 1990; 32(6):397-9. PubMed ID: 2101872
    [TBL] [Abstract][Full Text] [Related]  

  • 11. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.
    Hanada M; Delia D; Aiello A; Stadtmauer E; Reed JC
    Blood; 1993 Sep; 82(6):1820-8. PubMed ID: 8104532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death.
    Hockenbery D; Nuñez G; Milliman C; Schreiber RD; Korsmeyer SJ
    Nature; 1990 Nov; 348(6299):334-6. PubMed ID: 2250705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A bcl-2/IgH antisense transcript deregulates bcl-2 gene expression in human follicular lymphoma t(14;18) cell lines.
    Capaccioli S; Quattrone A; Schiavone N; Calastretti A; Copreni E; Bevilacqua A; Canti G; Gong L; Morelli S; Nicolin A
    Oncogene; 1996 Jul; 13(1):105-15. PubMed ID: 8700536
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The bcl-2 gene and protein in malignant lymphomas.
    Cleary ML
    Bull Cancer; 1991; 78(2):187-93. PubMed ID: 1903662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of the bcl-2 t(14;18) translocation and proto-oncogene expression in primary intraocular lymphoma.
    Wallace DJ; Shen D; Reed GF; Miyanaga M; Mochizuki M; Sen HN; Dahr SS; Buggage RR; Nussenblatt RB; Chan CC
    Invest Ophthalmol Vis Sci; 2006 Jul; 47(7):2750-6. PubMed ID: 16799010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of bcl-2 mRNA and protein in leukemia-lymphoma cell lines.
    Steube KG; Jadau A; Teepe D; Drexler HG
    Leukemia; 1995 Nov; 9(11):1841-6. PubMed ID: 7475272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absence of the t(14;18) chromosomal translocation in primary cutaneous B-cell lymphoma.
    Child FJ; Russell-Jones R; Woolford AJ; Calonje E; Photiou A; Orchard G; Whittaker SJ
    Br J Dermatol; 2001 Apr; 144(4):735-44. PubMed ID: 11298531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biology of the lymphomas: cytogenetics, molecular biology, and virology.
    Ambinder RF; Griffin CA
    Curr Opin Oncol; 1991 Oct; 3(5):806-12. PubMed ID: 1661167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative translocation breakpoint cluster region 5' to BCL-6 in B-cell non-Hodgkin's lymphoma.
    Butler MP; Iida S; Capello D; Rossi D; Rao PH; Nallasivam P; Louie DC; Chaganti S; Au T; Gascoyne RD; Gaidano G; Chaganti RS; Dalla-Favera R
    Cancer Res; 2002 Jul; 62(14):4089-94. PubMed ID: 12124346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bcl-2/JH rearrangements in benign lymphoid tissues with follicular hyperplasia.
    Limpens J; de Jong D; van Krieken JH; Price CG; Young BD; van Ommen GJ; Kluin PM
    Oncogene; 1991 Dec; 6(12):2271-6. PubMed ID: 1766674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.